Your blogger spent the past four days overeating in Rome and Tuscany and trying and failing to think of a Roman empire/Big Pharma joke, and all you'll get is this lousy weekend/early Monday roundup. What, you wanted a T-shirt?
- We came, we saw, we outsourced: AstraZeneca to offload all manufacturing activities, the Times is reporting this morning.
- Et tu, Dan? Via Reuters: "I have no indication that could confirm any rumours about tie-ups between big players in the sector," Vasella told French newspaper La Tribune in an interview.
- Ahead of Sanofi-Aventis' R&D meeting today, the company says it will bulk up in biologics. We'll have much more to say on the Big Pharma haves and have-nots in the biologics world in the next IN VIVO.